RecallRadar

FDA Drug recall D-0876-2023

Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater…

On 2023-06-21 the FDA classified a Class II recall of Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater… by Amneal Pharmaceuticals, citing failed Dissolution Specifications: Out-of-specification results for dissolution (above specification).

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0876-2023
ClassificationClass II
Statusterminated
Initiated2023-05-30
Published2023-06-21
Last updated2026-09-13 11:52 UTC
CompanyAmneal Pharmaceuticals
DistributionLA, OH, PA

Product

Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by: Amneal Pharmaceuticals LLC., Bridgewater, NJ 08807, NDC 65162-212-10.

Reason

Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)

Identifiers

ndc65162-212-03
ndc65162-212-10
ndc65162-212-50
ndc65162-212-11
code_infoLot # HL00721A, Exp. 12/2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0876-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.